Chart, page-1536

Yeah have to agree that cup and handle pattern does not seem to be playing out - handle has retraced too far. 

However double bottom pattern still in play. This looks quite likely with the amount of support at 11c.

Just needs a good announcement to start the reversal.

Hopefully one of the 3 main tactical priorities mentioned in the latest letter to shareholders:

• Partnering lead clinical program ‐ BIT225 for HIV‐1 eradication
• Partnering one or more preclinical programs – e.g. HBV
• Execute a regional licensing deal in China ‐ HCV program remains akey potential opportunity